NCT00387517View on ClinicalTrials.gov

Safety/Efficacy of Combo Therapy With Aliskiren & Hydrochlorothiazide vs Therapy With Hydrochlorothiazide Alone in Patients With Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

726

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Hypertension
Interventions
DRUG

Aliskiren/HCTZ

Trial Locations (2)

07936

Novartis Pharmaceuticals, East Hanover

Unknown

Investigative Centers

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY